Legend Biotech (LEGN) Revenue (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Revenue data on file, last reported at $306.3 million in Q4 2025.

• In Q4 2025, Revenue rose 64.24% year-over-year to $306.3 million; the TTM figure through Dec 2025 stood at $1.0 billion (up 64.02% YoY), while the FY2025 annual figure was $1.0 billion, up 64.02% from the prior year.
• Revenue grew to $306.3 million in Q4 2025, from $272.3 million in the prior quarter.
• Across five years, Revenue topped out at $79.5 billion in Q4 2023 and bottomed at $12.0 million in Q2 2022.
• A 5-year average of $4.1 billion and a median of $83.7 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue surged 287469.21% — and 2024, when it slumped 99.77%.
• Year by year, Revenue stood at $39.0 million in 2021, then decreased by 29.14% to $27.6 million in 2022, then surged by 287469.21% to $79.5 billion in 2023, then slumped by 99.77% to $186.5 million in 2024, then jumped by 64.24% to $306.3 million in 2025.
• The last three Revenue figures came in at $306.3 million (Q4 2025), $272.3 million (Q3 2025), and $255.1 million (Q2 2025), per Business Quant data.

Peer Comparison